$879.00 box of 1 - CSI # DBP-125SOLID145 - CSI Diamondback 360 Peripheral Orbital Atherectomy System, Solid Crown Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with its Diamondback 360 Coronary Orbital Atherectomy System (OAS). Among them, the DiamondBack 360 Peripheral Orbital Atherectomy System (Cardiovascular Systems, Inc) PRD-SC30-125. CSI Diamondback 360 Peripheral 1.25 Mm Micro 145 Cm Add to wishlist. Medical device company Cardiovascular Systems (CSI) has secured CE mark approval for its Diamondback 360 coronary orbital atherectomy system (OAS) and ViperWire In depth view into Cardiovascular Systems GF Value explanation, calculation, historical data and more Part # DBE-200 Exp 10/18. In Stock! The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. The Stealth 360 PAD System is CE Marked. DIAMONDBACK 360 Coronary Orbital Atherectomy System (OAS) Indication: To facilitate stent delivery in patients with coronary artery disease who are acceptable On April 20, 2015, Cardiovascular Systems, Inc. has received FDA clearance for the new 4 French (4 Fr) 1.25 Solid Diamondback 360 Peripheral Orbital Atherectomy System (OAS) for the treatment of peripheral artery disease (PAD). A number of atherectomy devices were developed in the last few years. October 22, 2013Cardiovascular Systems, Inc. (CSI; St. Paul, MN) announced that it has received premarket approval from the US Food and Drug Administration (FDA) to market ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Hong Kong has been treated with its Diamondback 360 PAUL, Minn., August 30, First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360 Coronary Orbital Atherectomy System - Diabetes $399.00. Description. Diamondback 360. The companys Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, Expired. MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM PERIPHERAL ATHERECTOMY DEVICE. Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series. Introduction of Orbital Atherectomy in Canada Expands Remedy Choices for Sufferers with Complicated Coronary Artery IllnessST. Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360 Coronary Orbital Atherectomy System (OAS).. CSI Cardiovascular Systems, Inc., Diamondback 360 Peripheral Orbital Atherectomy System, Model Number DBP-125MICRO145, Part Number 7-10003. In-Date Home; 3M; Abbott; Units in stock: 1 box of 1. $799.00 box of 1 - CSI # DB-SC30-175 - CSI Diamondback 360 Atherectomy System, 1.75mm Solid Crown Ships Today! Cardiovascular Systems, Inc. Ships Today! Over The Diamondback 360 Coronary OAS is FDA PMA approved. regular price. Ships Today! Product. CSI Diamondback 360 Peripheral Orbital Atherectomy Cartridge, Exchangeable Series, 1.25mm, 145cm, Micro, 4F. Cardiovascular Systems, Inc. Receives CE Mark for Diamondback regular price. Ships Today! The Global Atherectomy Devices Market size is expected to reach $900.7 million by 2025, rising at a market growth of 6.8% CAGR during the forecast period (2019-2025) CSI Headquarters 1225 Old Highway 8 NW (CSI) announced that Medikit, Co., Ltd. signed an item 1 CSI Diamondback 360 Peripheral System # DBP-200SOLID145 1 - CSI Diamondback 360 Peripheral System # DBP-200SOLID145. Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in ViperWire Advance and ViperWire Advance with Flex Tip Peripheral Guide Wires are designed specifically for the Diamondback 360 Peripheral Orbital Atherectomy Orbital atherectomy. On April 20, 2015, Cardiovascular Systems, Inc. has received FDA clearance for the new 4 French (4 Fr) 1.25 Solid Diamondback 360 Peripheral Orbital Atherectomy System (OAS) for the FDA Quick view. Over 400,000 of CSIs OAS devices have been sold to leading institutions worldwide. Ships Today! Minimally invasive, catheter based orbital atherectomy system; Facilitates 360 crown-vessel contact to sand away arterial calcium; Dual-action differential sanding and pulsatile force Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360 Coronary Orbital Atherectomy System (OAS). SurgiShop is a third-party distributor of high-end surgical disposables. ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) announced that the United States Food and Drug Administration (FDA) has approved the Diamondback 360 Coronary OAS Micro Crown system to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting CSI DBE-200 Stealth 360 Orbital Pad System is a minimally invasive catheter-based orbital atherectomy system (OAS) used to treat patients who suffer from peripheral arterial disease (PAD)caused by the accumulation of plaque in the leg or foot arteries, which reduces blood flow and can lead to In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. Diamondback 360 Coronary Orbital Atherectomy System (OAS) reduces severe calcium, enabling successful stent delivery to help optimize stent expansion and percutaneous coronary intervention (PCI) outcomes. The Diamondback 360 Coronary OAS utilizes a 1.25 mm eccentrically mounted diamond-coated crown. The Cardiovascular Systems, Inc. (CSI) DIAMONDBACK 360 Peripheral Orbital Atherectomy System (OAS) Exchangeable Series is a minimally invasive, catheter-based OAS designed for The Diamondback 360 Peripheral Orbital Atherectomy System The Diamondback 360 Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy system The Diamondback is a peripheral orbital atherectomy For further information call CSI at 1-877-274-0901 and/or consult CSIs website at www.csi360.com. regular price Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Cardiovascular Systems, Inc. (CSI ) (NASDAQ: In Stock! Stealth 360 Peripheral Orbital Atherectomy System Common Name: Intraluminal Artery Stripper Classificatio n: Class II, 21 CFR 870.4875 Product Code: MCW Predicate Device(s): cardiovascular systems diamondback 360 peripheral solid 1.75mm 180cm. February Ships Today! Over 400,000 of CSIs OAS devices have been sold to leading institutions Cardiovascular Systems Diamondback 360 Peripheral Orbital Atherectomy System - Sheath May Fracture During Use Recall Class: Class I Date Recall Initiated: May 23, 2014 Product: Diamondback 360 Peripheral Orbital Atherectomy System Model number: DPB-125MICRO145, Part number 7-10003. $199.00 box of 1 - CSI # PRD-SC30-200 - CSI Stealth 360 Peripheral Orbital Atherectomy System, Solid Crown 2.00mm csi diamondback 360 peripheral orbital atherectomy system 4 fr 1.25 solid 145cm - expired. Observational Study Evaluating the Efficacy of Orbital Atherectomy in Treating Calcified Coronary Lesions. In Stock! Diamondback 360 Coronary Orbital Atherectomy System (OAS) reduces severe calcium, enabling successful stent delivery to help optimize stent expansion and percutaneous coronary In Stock! CSI360 Diamondback. csi diamondback 360 peripheral orbital atherectomy system 4 fr 1.25 solid 145cm - expired. $799.00 box of 1 - CSI # DB-SC30-175 - CSI Diamondback 360 Atherectomy System, 1.75mm Solid Crown The Stealth 360 PAD System and Diamondback 360 PAD System received FDA 510(k) clearance. In Stock! The companys Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, A number of atherectomy devices were developed in the last few years. February 28, 2020. Orbital atherectomy (OA) is another atherectomy device being used for plaque modification, to reduce the total atheroma burden, to change the arterial compliance, and to decrease the vessel-wall trauma.50 The Diamondback 360 OAS is very similar to RA devices, as it uses a crown that is equivalent to the RA burr. The Stealth 360 Peripheral ST. 1 Ayat, Y, et al. Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in cardiovascular systems: dbp-150class145-each-expired csi ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and commercializing innovative Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in In Stock! The Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients Find many great new & used options and get the best deals for Dbp-125micro145 CSI Diamondback 360 Peripheral Orbital Atherectomy System at the best online prices at eBay! The Development Status - Commercial Events: Orbital Atherectomy System renamed Diamondback 360 Ghost Productions provided CSI360 with an animation of its Diamondback atherectomy system. Ships Today! CSI Diamondback 360 Peripheral Orbital Atherectomy System, Solid Crown, Exchangeable Series. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360 Coronary Orbital Atherectomy System (OAS). $879.00 box of 1 - CSI # DBP-125MICRO145 - CSI Diamondback 360 Peripheral Orbital Atherectomy System, Micro Crown IN-DATE. csi diamondback 360 peripheral orbital atherectomy system 5 fr 1.50 classic 145cm - expired. Diamondback 360 Coronary Orbital Atherectomy Systems Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital The Cardiovascular Systems, Inc. (CSI) DIAMONDBACK 360 Coronary Orbital Atherectomy System (OAS) is a catheter-based system designed for facilitating stent delivery in patients with CSI DBE-200 Stealth 360 Orbital Pad System. Catheter, peripheral, atherectomy - Product Code MCW: Product: DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM, 1.5MM SOLID, 145 CM, REF DBP Free shipping for many products! Quick view. $799.00 box of 1 - CSI # DB-SC30-150 - CSI Diamondback 360 Atherectomy System, 1.50mm Solid Crown Order Qty. If youre going to be in Madrid for the Spanish-speaking CSC 2021, dont miss the live case with Dr. Javier Escaned featuring the Diamondback 360 Coronary Orbital Atherectomy System. cardiovascular systems diamondback 360 peripheral solid 1.75mm 180cm. csi diamondback 360 peripheral orbital atherectomy system 5 fr 1.50 classic 145cm - expired. One solution to both reduce surface calcium and fracture deep calcium Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and In Stock! Expired. ST. PAUL, Minn., August 30, 2021--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360 Add to cart. In Stock! Ships Today! Add to cart. Millions of patients with PAD may benefit from treatment with orbital atherectomy utilizing the Diamondback 360 and Stealth 360 Peripheral Orbital Atherectomy Systems, CSII GF Value as of today (June 06, 2022) is $33.69. Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician. QUICK VIEW. Lot numbers: 100573, 100575, 100674, 100676, 100678, 100680. Cardiovascular Systems, Inc. CSI DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a real-world optical coherence tomography (OCT) imaging study of coronary OAS patients were released at EuroPCR The Diamondback 360 Exchangeable Series with GlideAssist is our most advanced OAS on the market for complete leg revascularization. The next gen device allows you to use multiple crowns with one handle to optimize your approach in treating multi-level disease cases. Cardiovascular Systems said initial data from a pivotal study show the Diamondback 360 Coronary Orbital Atherectomy System (OAS) for treatment of severely calcified lesions lowers stroke and Peripheral Orbital Atherectomy System Exchangeable Series. regular price $849.00 boston scientific wallflex colonic stent system w/ anchor lock delivery system 25mmx90mm-expired. Contact. The Stealth 360 Peripheral Orbital Atherectomy System (OAS) received CE Mark in October 2014. August 10, 2017Cardiovascular Systems, Inc. announced that a new subanalysis from the company's LIBERTY 360 study was presented as part of a late-breaking presentation at AMP 2017, the Amputation Prevention Symposium held August 912 in Chicago, Illinois. sale price sale. CSI DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM 4 FR 1.25 SOLID 145CM - EXPIRED. New Study Demonstrates Exceptional Performance With Cardiovascular Systems Diamondback 360 Coronary Orbital Atherectomy System (OAS) Dual Mode of Action. Peripheral Diamondback 1.50 Solid OAD, a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in Diamondback 360 Peripheral Orbital Atherectomy System. regular price $875.00 The study prospectively evaluated acute clinical outcomes of orbital atherectomy via transradial access for the treatment of peripheral artery disease (PAD) in lower-extremity lesions using CSIs 5-F extended length Diamondback 360 and Stealth 360 peripheral orbital atherectomy systems (OAS). $879.00 box of 1 - CSI # DBP-125MICRO145 - CSI Diamondback 360 Peripheral Orbital Atherectomy System, Micro Crown IN-DATE. It is currently performed only with the Diamondback 360 Peripheral Orbital Atherectomy System (Cardiovascular Systems Inc., St. Paul, MN, USA), which consisted of an orbiting eccentric diamond-coated crown mounted at the end of This article reviews the history, mechanism of action, evolution, $879.00 box of 1 - CSI # DBP-125SOLID145 - CSI Diamondback 360 Peripheral Orbital Atherectomy System, Solid Crown The OAS pump mounts directly onto an I.V. Pole and provides power and the pumping mechanism for the Diamondback 360 Orbital Atherectomy Systems. ViperSlide is an exclusive lubricant for use with CSIs Orbital Atherectomy Systems. sale price sale. Indications: The Diamondback 360 Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions. OAS Micro Crown Approved to Treat Severely Calcified Coronary Lesions Only Atherectomy Device Designed to Both Pilot Tight Lesions and Treat Up to 4mm Vessels with a Diamondback 360 Peripheral Orbital Atherectomy System 1.50 Solid 145cm Add to wishlist. Order Qty. CSI Coronary Innovation 13 Diamondback 360 with GlideAssist Nitinol ViperWire Advance with Flex Tip Diamondback 360 Orbital Atherectomy System Complex PCI Toolkit ECLIPSE Clinical Trial 2nd Generation Diamondback Enhanced navigation for lesion access and device removal in complex anatomy. cardiovascular systems: dbp-150class145-each-expired csi viperwire advance diamondback 360 coronary orbital atherectomy system 0.014" x 0.012" - expired. The U.S. FDA granted 510 (k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. Units in stock: 1 box of 1. In August 2021, Cardiovascular Systems, Inc. (CSI) announced that CardiRad Group signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy The Stealth 360 Peripheral Orbital Atherectomy System (OAS) received CE Mark in October 2014. Among them, the DiamondBack 360 Peripheral Orbital Atherectomy System (Cardiovascular Systems, Inc) was specifically designed to work in severely calcified plaque. DIAMONDBACK 360 Coronary Orbital Atherectomy System (OAS) Indication: To facilitate stent delivery in patients with coronary artery disease who are acceptable ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that Japans Ministry of Health, Labor and Welfare (MHLW) has approved the